Abstract
Publication details
- DOI
- 10.4103/0974-620x.64241
- Journal
- Oman Journal of Ophthalmology, 3(2), 99-100
- Publisher
- Medknow Publications
- Open access
- Gold open access
Cite this article
APA 7
Chhablani, J. K. (2010). Combined photodynamic therapy and intravitreal ranibizumab as treatment for extrafoveal choroidal neovascularization associated with age-related macular degeneration. Oman Journal of Ophthalmology, 3(2), 99-100. https://doi.org/10.4103/0974-620x.64241
MLA 9
Chhablani, Jay Kumar. "Combined photodynamic therapy and intravitreal ranibizumab as treatment for extrafoveal choroidal neovascularization associated with age-related macular degeneration." Oman Journal of Ophthalmology, vol. 3, no. 2, 2010, pp. 99-100. https://doi.org/10.4103/0974-620x.64241.
Chicago (author–date)
Chhablani, Jay Kumar. 2010. "Combined photodynamic therapy and intravitreal ranibizumab as treatment for extrafoveal choroidal neovascularization associated with age-related macular degeneration." Oman Journal of Ophthalmology 3 (2): 99-100. https://doi.org/10.4103/0974-620x.64241.
Harvard
Chhablani, J. K. (2010) 'Combined photodynamic therapy and intravitreal ranibizumab as treatment for extrafoveal choroidal neovascularization associated with age-related macular degeneration', Oman Journal of Ophthalmology, 3(2), pp. 99-100. doi:10.4103/0974-620x.64241.
Vancouver
Chhablani JK. Combined photodynamic therapy and intravitreal ranibizumab as treatment for extrafoveal choroidal neovascularization associated with age-related macular degeneration. Oman Journal of Ophthalmology. 2010;3(2):99-100. doi:10.4103/0974-620x.64241
IEEE
J. K. Chhablani, "Combined photodynamic therapy and intravitreal ranibizumab as treatment for extrafoveal choroidal neovascularization associated with age-related macular degeneration," Oman Journal of Ophthalmology, vol. 3, no. 2, pp. 99-100, 2010, doi: 10.4103/0974-620x.64241.